Martin Shkreli leaves after appearance on Capitol Hill in Washington before the House Committee on Oversight and Reform Committee, Feb. 4, 2016. (AP Photo/Susan Walsh, File)
October 13, 2026 03:04 PM EDT
FTC accuses Martin Shkreli of violating lifetime pharma ban
Martin Shkreli is under FTC scrutiny once again.
The agency and seven states asked a New York federal court on Tuesday to hold Shkreli in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Confirm Endpoints as a trusted biopharma news source
ENDPOINTS CAREERS